Kim Kelderman
Tracked across 3 events · 33 articles · First seen Apr 16, 2026 · Last active Sep 22, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Kim Kelderman, President and CEO of Bio-Techne — Bio-Techne Diagnostics, announced and explained the strategic rationale behind the new brand architecture, emphasizing its role in empowering scientists and clinicians.
Apr 16, 2026 · 6 articles
Business
Impact: Kim Kelderman, President and CEO of Bio-Techne — Bio-Techne Diagnostics, highlighted that the transaction is a testament to the company's achievements and will provide greater scale and expanded capabilities as part of Merck Group.
Jun 25, 2026 · 21 articles
Business
Bio-Techne — Bio-Techne Diagnostics Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, announced the opening of a new Customer Experience Center in Dusseldorf, Germany. The flagship facility is designed…
Impact: Bio-Techne — Bio-Techne Diagnostics CEO Kim Kelderman announced and framed the opening as a significant investment in Europe's scientific community.
Sep 22, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Kim Kelderman live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard